Prazinon Plus, 50 mg/144 mg/150 mg, tableta za pse
Prazinon Plus, 50 mg/144 mg/150 mg, tableta za pse
Authorised
- Febantel
- Pyrantel embonate
- Praziquantel
Product identification
Medicine name:
Prazinon Plus, 50 mg/144 mg/150 mg, tableta za pse
Active substance:
- Febantel
- Pyrantel embonate
- Praziquantel
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Febantel150.00/milligram(s)1.00Tablet
-
Pyrantel embonate144.00/milligram(s)1.00Tablet
-
Praziquantel50.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AA51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Croatia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Genera d.d.
Responsible authority:
- Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
- UP/I-322-05/22-01/728
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Croatian (PDF)
Published on: 23/05/2024